A phase II trial of reduced dose brentuximab vedotin for cutaneous T‐cell lymphomas Meeting Abstract
| Authors: | Khan, N.; Noor, S.; Geller, S.; Khodadoust, M. S.; Kheterpal, M.; Hancock, H.; Davey, T.; Ryu, S.; Perez, L.; Lares, A.; Ganesan, N.; Sohail, S.; Santarosa, A.; Galasso, N.; Kim, E.; Myskowski, P.; Kim, Y. H.; Horwitz, S.; Moskowitz, A. |
| Abstract Title: | A phase II trial of reduced dose brentuximab vedotin for cutaneous T‐cell lymphomas |
| Meeting Title: | 16th International Conference on Malignant Lymphoma - Virtual Edition |
| Journal Title: | Hematological Oncology |
| Volume: | 39 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Jun 18-22 |
| Meeting Location: | Virtual |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2021-06-01 |
| Start Page: | 294 |
| End Page: | 296 |
| Language: | English |
| ACCESSION: | 150945321 |
| DOI: | 10.1002/hon.123_2880 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| PUBMED: | 34105791 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 211 -- Accession Number: 150945321 -- Entry Date: In Process -- Revision Date: 20210618 -- Publication Type: Article -- Supplement Title: Jun2021 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: Cinahl |
